Endo USA, Inc. is a pharmaceutical manufacturer and part of Mallinckrodt-Endo. It lobbies on pharmacy and health issues, including domestic drug manufacturing, supply chain resilience, and programs like 340B and implementation of the Inflation Reduction Act and the Bipartisan Infrastructure Law. Filings show four reports totaling $230,000 and work with Foley & Lardner LLP.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
JARED RIFIS
The latest disclosures for this client.
FOLEY & LARDNER LLP
4TFOLEY & LARDNER LLP
Q3The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
FOLEY & LARDNER LLP
JENNIFER FITZGERALD WALSH
FOLEY & LARDNER LLP
mrs KATE M. KROS
FOLEY & LARDNER LLP
mr DENNIS ALAN CARDOZA
FOLEY & LARDNER LLP
FOLEY & LARDNER LLP
Q2FOLEY & LARDNER LLP
Q1